Experiment: 2RLT

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298
2	2D 1H-13C HSQC	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298
3	3D HNCA	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298
4	3D HNCO	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298
5	3D CBCA(CO)NH	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298
6	3D C(CO)NH	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298
7	3D HNCACB	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298
8	3D 1H-15N NOESY	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298
9	3D 1H-15N TOCSY	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298
10	3D 1H-13C NOESY	1 mM [U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] H2O, 1 mM [U-100% 13C; U-100% 15N] D2O	90% H2O/10% D2O		6.7	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	750

NMR Refinement
Method	Details	Software
	DGSA-distance geometry simulated annealing	X-PLOR

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	1
Representative Model	(minimized average structure)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	X-PLOR	3.851
2	refinement	X-PLOR	3.851

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.